ERK signaling mediates enhanced angiotensin II-induced rat aortic constriction following chronic intermittent hypoxia

Chinese Medical Journal

Volumn 126, Issue 17, 2013, Pages 3251-3258

  Guo, Xue Ling ^a   Deng, Yan ^a   Shang, Jin ^a   Liu, Kui ^a   Xu, Yong Jian ^a   Liu, Hui Guo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Chronic intermittent hypoxia; ERK1 2; Myosin light chain; Myosin phosphatase targeting subunit; Vasoconstriction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCHOLINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BETA ACTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL DIAMETER; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MORPHOMETRICS; NONHUMAN; OXYGEN CONCENTRATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SLEEP DISORDERED BREATHING; WEIGHT GAIN; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ANOXIA; AORTA; FLAVONOIDS; MALE; MAP KINASE SIGNALING SYSTEM; PHOSPHORYLATION; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 84883512100     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131439     Document Type: Article

References (41)

1. Lurie A. Cardiovascular disorders associated with obstructive sleep apnea. Adv Cardiol 2011; 46: 197-266.
2. He QY, Feng J, Zhang XL, Liang ZA, Huang SG, Kang J, et al. Elevated nocturnal and morning blood pressure in patients with obstructive sleep apnea syndrome. Chin Med J 2012; 125: 1740-1746.
3. Foster GE, Poulin MJ, Hanly PJ. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol 2007; 92: 51-65.
4. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45: 705-709.
5. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 2001; 90: 2007-2013.
6. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999; 34: 309-314.
7. Pepin JL, Tamisier R, Barone-Rochette G, Launois SH, Levy P, Baguet JP. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Resp Crit Care 2010; 182: 954-960.
8. Jackson-Weaver O, Paredes DA, Gonzalez Bosc LV, Walker BR, Kanagy NL. Intermittent hypoxia in rats increases myogenic tone through loss of hydrogen sulfide activation of large-conductance Ca(2+)-activated potassium channels. Circ Res 2011; 108: 1439-1447.
9. Kraiczi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000; 89: 493-498.
10. Webster BR, Osmond JM, Paredes DA, DeLeon XA, Jackson-Weaver O, Walker BR, et al. Phosphoinositide-dependent kinase-1 and protein kinase Cdelta contribute to endothelin-1 constriction and elevated blood pressure in intermittent hypoxia. J Pharmacol Exp Ther 2013; 344: 68-76.
11. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin in vascular smooth muscle cells. Pharmacol Rev 2000; 52: 639-672.
12. Cole WC, Welsh DG. Role of myosin light chain kinase and myosin light chain phosphatase in the resistance arterial myogenic response to intravascular pressure. Arch Biochem Biophys 2011; 510: 160-173.
13. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonist-and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 2006; 119: 1769-1780.
14. Do KH, Kim MS, Kim JH, Rhim BY, Lee WS, Kim CD, et al. Angiotensin-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway. Exp Mol Med 2009; 41: 569-576.
15. Ishihata A, Tasaki K, Katano Y. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 2002; 445: 247-256.
16. Ding L, Chapman A, Boyd R, Wang HD. Erk activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin-induced hypertension. Am J Physiol Heart Circ Physiol 2007; 292: H2997-H3005.
17. Escano CS Jr, Keever LB, Gutweiler AA, Andresen BT. Angiotensin activates extracellular signal-regulated kinase independently of receptor tyrosine kinases in renal smooth muscle cells: implications for blood pressure regulation. J Pharmacol Exp Ther 2008; 324: 34-42.
18. Touyz RM, He G, El Mabrouk M, Diep Q, Mardigyan V, Schiffrin EL. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by at1 receptors in vascular smooth muscle cells from Wistar-kyoto rats and spontaneously hypertensive rats. J Hypertens 2001; 19: 553-559.
19. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 1999; 84: 505-515.
20. Touyz RM, He G, Deng LY, Schiffrin EL. Role of extracellular signal-regulated kinases in angiotensin-stimulated contraction of smooth muscle cells from human resistance arteries. Circulation 1999; 99: 392-399.
21. Giachini FR, Sullivan JC, Lima VV, Carneiro FS, Fortes ZB, Pollock DM, et al. Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity. Hypertension 2010; 55: 172-179.
22. Hinojosa-Laborde C, Mifflin SW. Sex differences in blood pressure response to intermittent hypoxia in rats. Hypertension 2005; 46: 1016-1021.
23. Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, Caron F, Bessard G, Levy P, et al. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 2006; 150: 278-286.
24. de Frutos S, Caldwell E, Nitta CH, Kanagy NL, Wang J, Wang W, et al. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice. Am J Phsiol Heart Circ Physiol 2010; 299: H356-H363.
25. Sathishkumar K, Yallampalli U, Elkins R, Yallampalli C. Raf-1 kinase regulates smooth muscle contraction in the rat mesenteric arteries. J Vasc Res 2010; 47: 384-398.
26. Matrougui K, Eskildsen-Helmond YE, Fiebeler A, Henrion D, Levy BI, Tedgui A, et al. Angiotensin stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries. Hypertension 2000; 36: 617-621.
27. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
28. Allahdadi KJ, Walker BR, Kanagy NL. ROK contribution to endothelin-mediated contraction in aorta and mesenteric arteries following intermittent hypoxia/hypercapnia in rats. Am J Physiol Heart Circ Physiol 2007; 293: H2911-H2918.
29. Beguin PC, Belaidi E, Godin-Ribuot D, Levy P, Ribuot C. Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and ERK1/2. J Mol Cell Cardiol 2007; 42: 343-351.
30. Strniskova M, Ravingerova T, Neckar J, Kolar F, Pastorekova S, Barancik M. Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen Physiol Biophys 2006; 25: 25-41.
31. Wilkerson JE, Mitchell GS. Daily intermittent hypoxia augments spinal BDNF levels, ERK phosphorylation and respiratory long-term facilitation. Exp Neurol 2009; 217: 116-123.
32. Hoffman MS, Nichols NL, Macfarlane PM, Mitchell GS. Phrenic long-term facilitation after acute intermittent hypoxia requires spinal ERK activation but not TrkB synthesis. J Appl Physiol 2012; 113: 1184-1193.
33. Dyugovskaya L, Polyakov A, Cohen-Kaplan V, Lavie P, Lavie L. Bax/Mcl-1 balance affects neutrophil survival in intermittent hypoxia and obstructive sleep apnea: effects of p38MAPK and ERK1/2 signaling. J Transl Med 2012; 10: 211.
34. Han YJ, Hu WY, Chernaya O, Antic N, Gu L, Gupta M, et al. Increased myosin light chain kinase expression in hypertension: regulation by serum response factor via an insertion mutation in the promoter. Mol Biol Cell 2006; 17: 4039-4050.
35. D'Angelo G, Adam LP. Inhibition of ERK attenuates force development by lowering myosin light chain phosphorylation. Am J Physiol Heart Circ Physiol 2002; 282: H602-H610.
36. Xiao D, Pearce WJ, Longo LD, Zhang L. ERK-mediated uterine artery contraction: Role of thick and thin filament regulatory pathways. Am J Physiol Heart Circ Physiol 2004; 286: H1615-H1622.
37. Xiao D, Longo LD, Zhang L. Alpha1-adrenoceptor-mediated phosphorylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC. Am J Physiol Heart Circ Physiol 2005; 288: H2828-H2835.
38. Xiao D, Zhang L. ERK MAP kinases regulate smooth muscle contraction in ovine uterine artery: Effect of pregnancy. Am J Physiol Heart Circ Physiol 2002; 282: H292-H300.
39. Qi H, Wang P, Liu C, Li M, Wang S, Huang Y, et al. Involvement of HIF-1alpha in MLCK-dependent endothelial barrier dysfunction in hypoxia. Cell Physiol Biochem 2011; 27: 251-262.
40. Rembold CM, Wardle RL, Wingard CJ, Batts TW, Etter EF, Murphy RA. Cooperative attachment of cross bridges predicts regulation of smooth muscle force by myosin phosphorylation. Am J Physiol Cell Physiol 2004; 287: C594-C602.
41. Tsai MH, Jiang MJ. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle. Life Sci 2005; 76: 877-888.